DOX Stock Analysis: Amdocs | NASDAQ

Telecom Software, Cloud Platforms, AI Solutions, Consulting Services

Total Rating 43

Safety 67

Buy Signal -0.79

IT Consulting & Other Services
Sub-Industry Rotation: -8.7

Market Cap: 4.50B
Avg Turnover: 82.1M

Risk 3d forecast

Volatility67.4%

VaR 5^th Pctl11.6%

VaR vs Median4.57%

Reward TTM

Sharpe Ratio-1.12

Rel. Str. IBD6.1

Rel. Str. Peer Group5 pctl

Character TTM

Beta0.385

Beta Downside0.689

Hurst Exponent0.531

Choppyness46.9%

Drawdowns 3y

Max DD53.73%

CAGR/Max DD-0.31

CAGR/Mean DD-1.20

EPS (Earnings per Share)

EPS CAGR: 7.12%
EPS Trend: 95.6%

Last SUE: 1.54
Qual. Beats: 2

Revenue

Rev. CAGR: -3.26%
Rev. Trend: -82.4%

Last SUE: -0.44
Qual. Beats: 0

Warnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan -0.1% 0

Feb -0.6% 4

Mar +0.6% 4

Apr -0.1% 0

May +1.8% 4

Jun -0.3% 28

Jul +2.2% 28

Aug -0.9% 28

Sep -2.4% 28

Oct +0.5% 14

Nov -0.0% 0

Dec +0.2% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: DOX Amdocs

Amdocs Limited (NASDAQ: DOX) is a software and services provider serving communications, entertainment, and media service providers globally. The company offers a broad portfolio spanning customer experience, monetization, intelligent networking, charging, eSIM, and digital marketplace solutions, with its CES25 suite serving as a telco-native, GenAI-led platform that integrates AI agents across business, operations, and network domains. Its offerings include the Customer Engagement Platform (a telecom-specific CRM), Amdocs Monetization Suite, Amdocs Intelligent Networking Suite, Amdocs Charging, Amdocs eSIM Cloud, MarketONE (a SaaS-based digital services marketplace), connectX (a cloud-native telco-in-a-box platform), and CatalogONE (which embeds business intelligence with telecom-specific GenAI agents). Beyond software, Amdocs provides consulting, systems integration, managed services, network deployment and optimization, and professional services, including capabilities in predictive analytics and robotic process automation. Founded in 1982 and headquartered in Saint Louis, Missouri, the company has been publicly traded since its 1998 IPO.

Amdocs operates in the business support systems/operations support systems (BSS/OSS) segment of the IT services market, a specialized niche focused on helping telecommunications carriers run billing, customer management, and network operations. Its classification within the GICS Information Technology sector, under the IT Consulting & Other Services sub-industry, reflects its hybrid model that combines proprietary software products with recurring managed services revenue.

Headlines to Watch Out For

CES25 GenAI suite adoption drives managed services revenue growth
Strong dollar pressures margins on international revenue exposure
Competition from Accenture and Infosys pressures deal pricing

Piotroski VR-10 (Strict) 6.5

Net Income: 498.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA -1.54 > 1.0
NWC/Revenue: -2.20% < 20% (prev 5.15%; Δ -7.34% < -1%)
CFO/TA 0.11 > 3% & CFO 672.7m > Net Income 498.4m
Net Debt (1.06b) to EBITDA (1.03b): 1.02 < 3
Current Ratio: 0.94 > 1.5 & < 3
Outstanding Shares: last quarter (103.5m) vs 12m ago -5.79% < -2%
Gross Margin: 37.66% > 18% (prev 37.97%; Δ -0.31% > 0.5%)
Asset Turnover: 74.26% > 50% (prev 72.53%; Δ 1.73% > 0%)
Interest Coverage Ratio: 17.47 > 6 (EBIT TTM 824.1m / Interest Expense TTM 47.2m)

Altman Z'' 5.64

A: -0.02 (Total Current Assets 1.62b - Total Current Liabilities 1.72b) / Total Assets 6.40b
B: 1.15 (Retained Earnings 7.35b / Total Assets 6.40b)
C: 0.13 (EBIT TTM 824.1m / Avg Total Assets 6.32b)
D: 1.07 (Book Value of Equity 3.29b / Total Liabilities 3.06b)
Altman-Z'' = 5.64 = AAA

Beneish M -2.88

DSRI: 1.13 (Receivables 1.09b/935.8m, Revenue 4.70b/4.53b)
GMI: 1.01 (GM 37.97% / 37.66%)
AQI: 1.03 (AQ_t 0.61 / AQ_t-1 0.59)
SGI: 1.04 (Revenue 4.70b / 4.53b)
TATA: -0.03 (NI 498.4m - CFO 672.7m) / TA 6.40b)
Beneish M = -2.88 (Cap -4..+1) = A

What is the price of DOX shares?

As of November 13, 2026, the stock is trading at USD 44.11 with a total of 2,389,060 shares traded. Over the past week, the price has changed by +0.64%, over one month by -24.92%, over three months by -22.22% and over the past year by -40.87%.

Current recommended Stop Loss: 40.40 (which is 8.4% or 1.3 ATR below the current price).

Is DOX a buy, sell or hold?

Amdocs has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy DOX.

StrongBuy: 3
Buy: 0
Hold: 3
Sell: 0
StrongSell: 0

What are the forecasts/targets for the DOX price?

Analysts Target Price	57.3	30%

Amdocs (DOX) - Fundamental Data Overview as of 13 November 2026

Market Cap USD = 4.50b (4.50b USD * 1.0 USD.USD)
P/E Trailing = 9.2137
P/E Forward = 5.0
P/S = 0.9586
P/B = 1.315
P/EG = 0.5557
Revenue TTM = 4.70b USD
EBIT TTM = 824.1m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 647.4m USD (from longTermDebt, two quarters ago)
Short Term Debt = 331.6m USD (from shortTermDebt, last quarter)
Debt = 1.25b USD (from shortLongTermDebtTotal, last quarter) + Leases 159.6m
Net Debt = 1.06b USD (calculated: Debt 1.25b - CCE 197.0m)
Enterprise Value = 5.56b USD (4.50b + Debt 1.25b - CCE 197.0m)
Interest Coverage Ratio = 17.47 (Ebit TTM 824.1m / Interest Expense TTM 47.2m)
EV/FCF = 9.89x (Enterprise Value 5.56b / FCF TTM 562.2m)
FCF Yield = 10.11% (FCF TTM 562.2m / Enterprise Value 5.56b)
FCF Margin = 11.97% (FCF TTM 562.2m / Revenue TTM 4.70b)
Net Margin = 10.61% (Net Income TTM 498.4m / Revenue TTM 4.70b)
Gross Margin = 37.66% ((Revenue TTM 4.70b - Cost of Revenue TTM 2.93b) / Revenue TTM)
Gross Margin QoQ = 36.81% (prev 39.76%)
Tobins Q-Ratio = 0.87 (Enterprise Value 5.56b / Total Assets 6.40b)
Interest Expense / Debt = 3.76% (Interest Expense 47.2m / Debt 1.25b)
Taxrate = 21.16% (134.5m / 635.8m)
NOPAT = 649.7m (EBIT 824.1m * (1 - 21.16%))
Current Ratio = 0.94 (Total Current Assets 1.62b / Total Current Liabilities 1.72b)
Debt / Equity = 0.38 (Debt 1.25b / totalStockholderEquity, last quarter 3.29b)
Debt / EBITDA = 1.02 (Net Debt 1.06b / EBITDA 1.03b)
Debt / FCF = 1.88 (Net Debt 1.06b / FCF TTM 562.2m)
Total Stockholder Equity = 3.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.88% (Net Income 498.4m / Total Assets 6.40b)
RoE = 14.89% (Net Income TTM 498.4m / Total Stockholder Equity 3.35b)
RoCE = 20.64% (EBIT 824.1m / Capital Employed (Equity 3.35b + L.T.Debt 647.4m))
RoIC = 13.50% (NOPAT 649.7m / Invested Capital 4.81b)
WACC = 6.08% (E(4.50b)/V(5.76b) * Re(6.94%) + D(1.25b)/V(5.76b) * Rd(3.76%) * (1-Tc(0.21)))
Discount Rate = 6.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.32 | Cagr: -4.78%
[DCF] Terminal Value 73.48% ; FCFF base≈595.4m ; Y1≈533.1m ; Y5≈448.9m
[DCF] Fair Price = 58.54 (EV 7.17b - Net Debt 1.06b = Equity 6.11b / Shares 104.4m; r=8.35% [WACC [floored]]; 5y FCF grow -12.86% → 2.50% )
EPS Correlation: 95.63 | EPS CAGR: 7.12% | SUE: 1.54 | # QB: 2
Revenue Correlation: -82.44 | Revenue CAGR: -3.26% | SUE: -0.44 | # QB: 0
EPS current Quarter (2026-12-31): EPS=1.30 | Chg30d=-32.63% | Revisions=-40% | Analysts=5
EPS next Quarter (2027-03-31): EPS=1.34 | Chg30d=-31.82% | Revisions=-17% | Analysts=5
EPS current Year (2027-09-30): EPS=5.38 | Chg30d=-32.96% | Revisions=+29% | GrowthEPS=-27.4% | GrowthRev=-16.0%
EPS next Year (2028-09-30): EPS=6.12 | Chg30d=-33.43% | Revisions=+40% | GrowthEPS=+13.7% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: +7% (up=6, down=5)